Increasing Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Rising Global Travel And Cross-Border Pathogen Spread: Pivotal Factor Influencing Syndromic Multiplex Diagnostics Market Growth in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Syndromic Multiplex Diagnostics Market Size Growth Forecast: What to Expect by 2025?
The market size of syndromic multiplex diagnostics has witnessed a swift escalation lately. Projected to grow from a significant $3.11 billion in 2024 to an admirable $3.43 billion in 2025, this market will advance at a compound annual growth rate (CAGR) of 10.0%. Several catalysts have spurred growth during the historical period, such as the mounting demand for speedy and precise diagnostics, heightened public awareness regarding early disease detection, escalating instances of hospital-acquired infections, the popularity of molecular diagnostics on the rise, increased expenditure in the healthcare sector, and fresh emphasis on point-of-care testing.

How Will the Syndromic Multiplex Diagnostics Market Size Evolve and Grow by 2029?
In the coming years, the syndromic multiplex diagnostics market is projected to experience substantial growth, likely hitting a valuation of $4.96 billion by 2029, marking an impressive 9.7% compound annual growth rate (CAGR). This expected growth within the forecast period is driven by factors such as elevated investments in research and development, growing acceptance in environments with limited resources, enhanced healthcare facilities in developing nations, increased government efforts aimed at controlling infectious diseases, and surging demand for localized testing. Furthermore, other significant trends we will likely see throughout the period include the evolution of multiplex polymerase chain reaction (PCR) technologies, breakthroughs in microfluidics and lab-on-chip systems, advanced automation in specimen processing, innovative point-of-care molecular platforms, the incorporation of cloud-based diagnostic data systems, and developments in mobile diagnostic devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/syndromic-multiplex-diagnostics-global-market-report

What Drivers Are Propelling the Growth of Syndromic Multiplex Diagnostics Market Forward?
Anticipated growth in the syndromic multiplex diagnostics market can be attributed to the escalating prevalence of infectious diseases. These diseases are caused by harmful organisms like bacteria, viruses, fungi, or parasites that invade the body, multiply, and result in symptoms and health issues. The rise in such diseases is facilitated by increased worldwide travel, which fast-tracks the transmission of pathogens across international borders and populations. Syndromic multiplex diagnostics play a crucial role in managing infectious diseases by permitting the prompt and simultaneous identification of multiple pathogens from a single sample. This, in turn, enhances diagnostic precision and speed, promoting timely treatment decisions and improved patient outcomes. For example, the Centers for Disease Control and Prevention, a US-based national public health institution, reported that there were 8,331 tuberculosis (TB) cases in 2022, a 5.9% surge from 7,874 cases in 2021 in March 2023. As such, the rising prevalence of infectious diseases is fuelling the growth of the syndromic multiplex diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27427&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Syndromic Multiplex Diagnostics Market?
Key players in the syndromic multiplex diagnostics market are turning their attention to the creation of sophisticated solutions such as artificial intelligence-powered diagnostic algorithms to bolster the speed, precision, and range of pathogen identification. These advanced diagnostic algorithms utilizing artificial intelligence, specifically machine learning and deep learning, allow for the rapid and precise analysis of complex clinical and lab data for expedited and improved disease diagnosis. The molecular diagnostics firm from Netherlands, Qiagen N.V., for example, introduced two syndromic testing panels, the Gastrointestinal Panel 2 and the Meningitis and Encephalitis Panel, for their QIAstat Dx platform in January 2024. These panels facilitate the quick and precise diagnosis of infectious diseases by enabling multiple pathogen detection in a single test, thereby aiding clinical decision-making and improving patient results. The QIAstat-Dx system combines cutting-edge data analytics to assist healthcare professionals in promptly identifying and managing infectious disease epidemics.

What Are the Key Segments in the Syndromic Multiplex Diagnostics Market?
The syndromic multiplex diagnostics market covered in this report is segmented

1) By Product Type: Instruments, Reagents, Software And Services
2) By Sample Type: Blood Samples, Urine Samples, Saliva Samples, Tissue Samples
3) By Technology: Polymerase Chain Reaction, Mass Spectrometry, Nucleic Acid Amplification Tests, Next-Generation Sequencing
4) By Application: Infectious Diseases, Respiratory Diseases, Gastrointestinal Diseases, Sexually Transmitted Infections, Central Nervous System Diseases
5) By End User: Clinical Laboratories, Hospitals, Pharmaceutical And Biotechnology Companies, Research Institutes, Other End Users

Subsegments:
1) By Instruments: Real-Time Polymerase Chain Reaction (PCR) Systems, Microfluidic-Based Systems, Automated Sample-To-Answer Systems, Cartridge-Based Systems, Multiplex Polymerase Chain Reaction (PCR) Platforms
2) By Reagents: Assay Panels, Primers And Probes, Enzymes, Buffers And Solutions, Sample Preparation Reagents
3) By Software And Services: Data Analysis Software, Cloud-Based Diagnostic Platforms, Integration And Connectivity Solutions, Technical Support Services, Maintenance And Calibration Services, Training And Installation Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27427&type=smp

Who Are the Key Players Shaping the Syndromic Multiplex Diagnostics Market's Competitive Landscape?
Major companies operating in the syndromic multiplex diagnostics market are Roche Molecular Systems Inc., Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Cepheid, Bosch Healthcare Solutions GmbH, Biocartis NV, Luminex Corporation, Curetis GmbH, Accelerate Diagnostics Inc., Applied BioCode Inc., Ador Diagnostics Ltd., Akonni Biosystems Inc., Alveo Technologies Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, Nanomix Inc., Primerdesign Ltd.

What Geographic Markets Are Powering Growth in the Syndromic Multiplex Diagnostics Market?
North America was the largest region in the syndromic multiplex diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the syndromic multiplex diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27427

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.